The Ocular Surface ( IF 5.9 ) Pub Date : 2020-11-08 , DOI: 10.1016/j.jtos.2020.11.002 Onkar B Sawant 1 , Sneha Singh 2 , Robert Emery Wright 2 , Kayla M Jones 1 , Michael S Titus 3 , Eugene Dennis 4 , Eric Hicks 3 , Parag A Majmudar 5 , Ashok Kumar 2 , Shahzad I Mian 6
Background
SARS-CoV-2 is found in conjunctival swabs and tears of COVID-19 patients. However, the presence of SARS-CoV-2 has not been detected in the human eye to date. We undertook this study to analyze the prevalence of SARS-CoV-2 in human post-mortem ocular tissues.
Methods
The expression of SARS-CoV-2 RNA was assessed by RT-PCR in corneal and scleral tissues from 33 surgical-intended donors who were eliminated from a surgical use per Eye Bank Association of America (EBAA) donor screening guidelines or medical director review or positive COVID-19 test. Ocular levels of SARS-CoV-2 RNA (RT-PCR), Envelope and Spike proteins (immunohistochemistry) and anti-SARS-CoV-2 IgG and IgM antibodies (ELISA) in blood were evaluated in 10 COVID-19 donors.
Findings
Of 132 ocular tissues from 33 surgical-intended donors, the positivity rate for SARS-CoV-2 RNA was ∼13% (17/132). Of 10 COVID-19 donors, six had PCR positive post-mortem nasopharyngeal swabs whereas eight exhibited positive post-mortem anti-SARS-CoV-2 IgG levels. Among 20 eyes recovered from 10 COVID-19 donors: three conjunctival, one anterior corneal, five posterior corneal, and three vitreous swabs tested positive for SARS-CoV-2 RNA. SARS-CoV-2 spike and envelope proteins were detected in epithelial layer of the corneas that were procured without Povidone-Iodine (PVP–I) disinfection.
Interpretations
Our study showed a small but noteworthy prevalence of SARS-CoV-2 in ocular tissues from COVID-19 donors. These findings underscore the criticality of donor screening guidelines, post-mortem nasopharyngeal PCR testing and PVP-I disinfection protocol to eliminate any tissue harboring SARS-CoV-2 being used for corneal transplantation.
中文翻译:
人类死后眼组织中 SARS-CoV-2 的患病率
背景
在 COVID-19 患者的结膜拭子和眼泪中发现了 SARS-CoV-2。然而,迄今为止,尚未在人眼中检测到 SARS-CoV-2 的存在。我们进行这项研究是为了分析人类死后眼组织中 SARS-CoV-2 的流行情况。
方法
通过 RT-PCR 评估了 33 名拟手术捐献者的角膜和巩膜组织中 SARS-CoV-2 RNA 的表达,这些捐献者根据美国眼库协会 (EBAA) 捐献者筛选指南或医疗主任审查被排除在手术用途之外。 COVID-19 检测呈阳性。对 10 名 COVID-19 捐献者的血液中 SARS-CoV-2 RNA (RT-PCR)、包膜蛋白和刺突蛋白(免疫组织化学)以及抗SARS-CoV-2 IgG 和 IgM 抗体 (ELISA) 的眼部水平进行了评估。
发现
在来自 33 名手术捐赠者的 132 份眼组织中,SARS-CoV-2 RNA 的阳性率为 ∼13% (17/132)。在 10 名 COVID-19 捐献者中,有 6 名死后鼻咽拭子 PCR 呈阳性,而 8 名死后抗SARS-CoV-2 IgG 水平呈阳性。从 10 名 COVID-19 捐献者身上恢复的 20 只眼睛中:3 只结膜、1 只前角膜、5 只后角膜和 3 只玻璃体拭子检测出 SARS-CoV-2 RNA 呈阳性。在未经聚维酮碘 (PVP-I) 消毒的角膜上皮层中检测到 SARS-CoV-2 刺突蛋白和包膜蛋白。
解释
我们的研究表明,在 COVID-19 捐赠者的眼组织中,SARS-CoV-2 的患病率虽小,但值得注意。这些发现强调了供体筛选指南、尸检鼻咽 PCR 检测和 PVP-I 消毒方案的重要性,以消除用于角膜移植的任何含有 SARS-CoV-2 的组织。